Cadence Pharmaceuticals (CADX)
Add to Watchlists Create an Alert
6.965
+0.27 +3.96%
NASDAQ
May 23, 4:59PM
BATS Real time
Currency in USD
Cadence Pharmaceuticals Return on Assets:
-50.59% for March 31, 2013Cadence Pharmaceuticals Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -50.59% |
| Dec. 31, 2012 | -61.56% |
| Sept. 30, 2012 | -65.08% |
| June 30, 2012 | -68.07% |
| March 31, 2012 | -65.76% |
| Dec. 31, 2011 | -65.44% |
| Sept. 30, 2011 | -67.92% |
| June 30, 2011 | -62.56% |
| March 31, 2011 | -62.17% |
| Dec. 31, 2010 | -57.82% |
| Sept. 30, 2010 | -61.55% |
| June 30, 2010 | -55.79% |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
CADX Return on Assets Benchmarks
| Companies | |
|---|---|
| Bristol-Myers Squibb | 4.27% |
| Dendreon | -45.96% |
| Targacept | -8.53% |
CADX Return on Assets Rankings
| Overall |
43rd percentile 4554 of 8006 |
| Sector |
39th percentile 412 of 686 in Healthcare |
| Industry |
54th percentile 113 of 248 in Biotechnology |
CADX Return on Assets Range, Past 5 Years
| Minimum | -75.30% | Dec 2008 |
| Maximum | -46.02% | Dec 2009 |
| Average | -60.89% |